PREVALENCE OF HEPATITIS B SURFACE ANTIGEN CARRIER STATE IN PATIENTS WITH LICHEN PLANUS–REPORT OF 200 CASES FROM LAHORE, PAKISTAN
Abstract
Background: To determine the prevalence of hepatitis B surface antigen carrier state in patientswith lichen planus. Methods: A quasi experimental cross sectional study was done at Departmentof Dermatology, Shaikh Zayed Federal Postgraduate Medical Institute, Lahore, Pakistan, fromApril 2003 to March 2005. Two hundred clinically diagnosed cases of LP and equal number ofpatients with other dermatoses not reportedly associated with hepatitis B virus (HBV) infection(control group) were collected from Skin Out Patient Department. They were screened forhepatitis B surface antigen (HBsAg) by Enzyme Linked Immunosorbent Assay (ELISA).Statistical analysis was done by using SPSS package version 11. Results: Out of 200 patients ofeach group, three patients with LP and seven patients from control group were positive forHBsAg. The test of significance for proportions revealed that there was no significant difference(p>0.1) between two groups. Conclusion: No association between HBsAg carrier state and LPwas found in our study.Key Words: Lichen Planus; Hepatitis B surface antigen.References
Lowe N J, Cudworth AG, Woodrow JC. HLA antigen in
lichen plus. Br J Dermatol 1976;95:169–71.
Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T–
cell clones in lichen planus. Br J Dermatol 2000;142:449–56.
Kawamura E, Nakamura S, Sasaki M, Ohyama Y, Kadena T,
Kumamaru W, et al. Accumulation of oligoclonal T cells in
the infiltrating lymphocytes is oral lichen planus. J Oral
Patho Med 2003;32:282–9.
Kofoed ML, Wantzin GL. Familial lichen planus – more
frequent than previously suggested? J Am Acad Dermatol
;13:50–4.
Graells J, Notario J, Badia F. Lichen planus in monozygotic
twins. Clin Exp Dermatol 1998;23:299.
J Ayub Med Coll Abbottabad 2007;19(4)
Halery S, Feuerman EJ. Abnormal glucose tolerance
associated with lichen planus. Acta Derm Venereol (stockh)
;59:167–70.
Almeyda J, Levontine A. Lichenoid drug eruptions. Br J
Dermatol 1971;85:604-7.
Vallejo GMJ, Huerta G, Cerero R, Seoane JM. Anxiety and
depression as risk factors for oral lichen planus. Dermatology
;203:303-7.
Monk B. Lichen planus and the liver. J Am Acad Dermatol
;12:122–3.
Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri
NG, Gasbarrini G. HCV infection and extrahepatic
manifestations. Hepatogastroenterology 2003;50:1149-54.
Graham-Brown RAC, Sarkany I, Sherlock S. Lichen planus and
primary biliary cirrhosis. Br J Dermatol 1982;106:699-703.
Cottoni F, Solinas A, Piga MR, Tocco A, Lissia M, Cerimele D
et al. Lichen planus, chronic liver disease and immunologic
involvement. Arch Dermatol Res 1988;208:555-60.
Ayala F, Balato N, Tranfaglia, Guadagnino V, Orlando R. Oral
erosive lichen planus and chronic liver disease. J Am Acad
Dermatol 1986;14:139-40.
Dogan B. Dermatological manifestations in hepatitis B surface
antigen carriers in east region of Turkey. J Eur Acad Dermatol
Venereol 2005;19:323-5.
Daramola OO,George AO, Ogunbiyi AO, Otegbayo JA.
Hepatitis B virus in Nigerians with lichen planus. West Afr J
Med 2004;23:104-6.
Denli YG, Durdu M, Karaksa M. Diabetes and hepatitis
frequency in 140 lichen planus cases in Cukurova region. J
Dermatol 2004;31:293-8.
Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Derarosi F
et al. Lichen palnus and hepatitis C virus: a multicenter study of
patients with oral lesions and a systemic review. Br J Dermatol
;151:1172-81.
Mahboob A, Haroon TS, Iqbal Z, Iqbal F, Butt AK. Frequency
of anti HCV antibodies in patients with lichen planus. J Coll
Physician Surg Pak 2003;1:248-51.
Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K,
Setoyama M. Analysis of hepatitis C virus (HCV) RNA in the
lesions of lichen planus with chronic hepatitis C: detection of
antigenomic as well as genomic strand HCV RNAs in lichen
planus lesions. J Dermatol Sci 2003;32:65-70.
Assad T, Samdani AJ. Association of lichen palnus with
hepatitis C virus infection. Ann Saudi Med 2005;25:243–6.
Podanyi B, Lengyel G, Kiss A, Szakonyi J, Schaff Z, Feher J.
Association of chronic hepatitis C infection and lichen
planus. Orv Hetil 2006;147:547-50.
Kane M. Global programme for control of hepatitis B
infection. Vaccine 1995;13:547-9.
Andre F. Hepatitis B epidemiology in Asia, the Middle East
and Africa. Vaccine 2000;18:S20-2.
Ali N, Khattak J, Anwar M, Tariq WZ, Nadeem M et al.
Prevalence of hepatitis B surface antigen and hepatitis C
antibodies in young healthy adult. Pakistan J Pathol
;13:3-6.
Khattak MF, Salamat N, Bhatti FA, Qureshi TZ.
Seroprevalence of hepatitis B, C and HIV in northern
Pakistan. J Pak Med Assoc 2002;52:398-402.
Khokhar N, Gill ML, Malik GJ. General seroprevalence of
hepatitis B and hepatitis C virus infection in population. J
Coll phys Surg Pak 2004;12:534-6.
Chaudhary IA, Khan SA, Samiullah. Should we do hepatitis
B and C screening on each patient before surgery. Analysis
of 142 cases. Pak J Med Sci 2005:21:278-80.
Shah SMA, Khan MT, Zahour ullah, Ashfaq NY. Prevalence
of hepatitis B and Hepatitis C virus infection in
multitransfused thalassaemia major patients in northwest
frontier province. Pak J Med Sci 2005;21:281-4.
Shazi L, Abbas Z. Comparison of risk factors for hepatitis B
and C patients visiting a Gastroenterology clinic. JCPSP
;16:104-7.
Krugman S, Overby LR, Mushahwar IK, Ling CM, Frösner
GG, Deinhardt F. Viral hepatitis, type B. Studies on natural
history and prevention re-examined. N Engl J Med
;300:101-6.
Rinker J. Galambos JT. Prospective study of hepatitis B in
thirty-two nadvertently infected people. Gastroenterology
;9:97-115.
McElgunn Patrick SJ. Dermatologic manifestations of hepatitis
B virus infection. J Am Acad Dermatol 1983;8:539-48.
Kirtsching G, Wakelin SH, Wojnarowska F. Mucosal vulval
lichen planus: outcome, clinical and laboratory features. J
Eur Acad Dermatol Venereol 2005;19:301-7.
Bokor-Bratic M. Lack of evidence of hepatic disease in patients
with oral lichen planus in Serbia. Oral Dis 2004;10:283-6.
Míco-Llorens JM, Delgado-Molina E, Baliellas-Comellas C,
Berini-Aytés L, Gay-Escoda C. Association between B
and/or C chronic viral hepatitis and oral lichen planus. Med
Oral 2004;9:183-90.
Cooper SM, Kirtschig G, Jeffery KJ, Wojnarowska F. No
association between hepatitis B or C viruses and vulval
lichen planus in a UK population. BJOG 2004;111:271-3.
Ciaccio M, Rebora A. Lichen planus following HBV
vaccination: A coincidence? Br. J Dermatol 1990;22:424.
Limas C, Limas CJ. Lichen planus in children: a possible
complication of hepatitis B vaccines. Pediatr Dermatol
;19:204-9.
Agrawal A, Shenoi SD. Lichen planus secondary to hepatitis B
vaccination. Indian J. Dermatol venereal leprol 2004;70:234-5.
Calista D, Morri M. Lichen planus induced by hepatitis B
vaccination: a new case and review of the literature. Int J
Dermatol 2004;43:562-4.
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
